LivaNova Plc (LIVN)
LivaNova Market Cap : 4.235B for June 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Smith & Nephew plc | 13.98B |
| NovoCure Ltd. | 1.997B |
| AstraZeneca PLC | 568.50B |
| Axogen, Inc. | 2.280B |
| Tandem Diabetes Care, Inc. | 1.205B |
Market Cap Related Metrics
| PE Ratio | 39.82 |
| PS Ratio | 2.977 |
| Price to Book Value | 3.496 |
| Price to Free Cash Flow | 26.50 |
| Price | 77.14 |
| Earnings Yield | 2.51% |
| Operating PE Ratio | 20.10 |
| Normalized PE Ratio | 26.35 |